ArticleFrontiers in oncology2025
Diagnosis and treatment of hepatic hilar lymph node metastasis in hepatic alveolar echinococcosis patients: a real-world single-center experience.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In patients with hepatic alveolar echinococcosis (HAE), germinal cells of Materials and methods: We retrospectively reviewed patients with HAE who underwent radical hepatectomy combined with systematic hepatic hilar LN dissection and targeted LN resection (SHD-TR) at our center from January 2016 to April 2025. We collected patients' clinical data, imaging characteristics, surgical outcomes, and recurrence rates. Univariate and multivariate analyses were conducted to identify independent predictive factors for HAE hepatic hilar LN metastasis to construct a prediction model. Receiver operating characteristic (ROC) curves, precision-recall (PR) curves, calibration curves, and decision curve analysis (DCA) were used to evaluate the predictive performance of the model. Results: The independent predictive factors included LN diameter, nodular calcification, and nonenhancement. Recurrent disease was seen in four patients without LN metastasis and two patients with LN metastasis. Kaplan-Meier curves revealed no significant difference in disease-free survival (DFS) between the two groups ( Conclusion: The prognosis of hepatic hilar LN metastasis is similar to that of HAE without metastasis. Radical hepatectomy combined with SHD-TR is safe and effective for HAE patients with LN metastasis. The prediction model based on LN diameter, nodular calcification, and nonenhancement has a strong and stable discrimination ability for HAE LN metastasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.